✦ LIBER ✦

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

✍ Scribed by Wressnigg, Nina; Pöllabauer, Eva-Maria; Aichinger, Gerald; Portsmouth, Daniel; Löw-Baselli, Alexandra; Fritsch, Sandor; Livey, Ian; Crowe, Brian A; Schwendinger, Michael; Brühl, Peter; Pilz, Andreas; Dvorak, Thomas; Singer, Julia; Firth, Clair; Luft, Benjamin; Schmitt, Bernhard; Zeitlinger, Markus; Müller, Markus; Kollaritsch, Herwig; Paulke-Korinek, Maria; Esen, Meral; Kremsner, Peter G; Ehrlich, Hartmut J; Barrett, P Noel

Book ID: 120332778
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 255 KB
Volume: 13
Category: Article
ISSN: 1473-3099
DOI: 10.1016/S1473-3099(13)70110-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of an enterovi

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

✍ Zhu, Feng-Cai; Liang, Zheng-Lun; Li, Xiu-Ling; Ge, Heng-Ming; Meng, Fan-Yue; Mao 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 166 KB

Safety and immunogenicity of SC599, an o

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

✍ Odile Launay; Christine Sadorge; Nathalie Jolly; Béatrice Poirier; Stéphane Béch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 795 KB

Immunogenicity and safety of the Vi-CRM1

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

✍ Bhutta, Zulfiqar A; Capeding, Maria Rosario; Bavdekar, Ashish; Marchetti, Elisa; 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 276 KB